View Article

Abstract

Cancer is a major health issue in the world causing an uncontrollable division of abnormal cell in the body and destroy body tissue leading to death of the person. There are over 100 types of cancer. They are usually named for the organ or tissue where the cancer form. There are many drugs available for treatment of cancer but no drug is found effective and safe. Herbal medicines have a vital role in prevention and treatment of cancer. They show their anti-cancer effect by inhibiting cancer activating harmones and enzymes, repairing DNA, enhancing immunity of body and producing protective enzymes. More than 50% of modern drugs in clinical use are of natural products. In the present review, an attempt has been made to study the plants that have been used in the treatment of cancer.

Keywords

Cancer, cancer therapy, herbal medication, medicinal plants, cell aptosis, ayurvedic concept.

Introduction

1.1. Herbal Formulations:

Although there are many different Ayurvedic methods and approaches to health, studies of herbs and botanical formulations make up the majority of published Ayurvedic research. Hundreds of Ayurvedic herbs have been utilized for approved medical purposes for millennia, as documented in Ayurvedic scriptures (Arnold Julia T 2023). Many therapeutic plants have anticancer properties and can be used to treat clinical and/or experimental malignancies and tumors of different organs. Sarcoma, leukemia, lymphoma, and carcinoma are a few of those malignancies. Medicinal herbs are recognized for their diverse antioxidant and immunomodulatory qualities, which result in anticancer effects. They work by promoting both innate immunity and acquired immunity. By restoring bodily balance and training bodily tissue, they could enhance host resistance to infection. (Pandey Govind 2011). It is well known that several biological response modifiers obtained from herbs might impede growth. While herbal extracts are generally helpful, it should be noted that in pediatric oncology situations, there may be some herb-drug interactions between medications and herbal medicines. This is because conventional drugs usually have one pharmacologically active component, whereas herbal agents often contain multiple. Many patients use specific complementary and alternative medicine (CAM) techniques in the hopes that the tumor would respond therapeutically, potentially curing their illness. The general public believes herbal medications to be safe, to have fewer adverse effects, and to reduce the risk of drug dependency. However, the use of complementary and alternative medicine (CAM) in cancer treatment is not well studied in English clinical research, which has limited the number of studies on anticancer treatments. (Ali Mohammadi et al 2017).

It has been shown that vitamin and herbal components can treat over 60% of cancer cases. Since ancient times, herbal medicines (HMs) have been used to treat a wide range of ailments and alleviate pain due to their superior biological qualities. Additionally, HMs have shown amazing antitumor properties. In addition to inducing apoptosis, regulating mRNAs, raising the amounts of those protecting enzymes, boosting the immune system, and exerting antioxidant activity, HM components also activate DNA repair pathways. The World Health Organization states that because chemotherapy is expensive, 80%          of village residents rely solely on HMs as their primary healthcare provider. Normal cells in the body are also impacted by the chemicals and radiation therapy used to treat cancer cells. (Abdulridha MK et al 2020)

1.2. Cancer:

The word "cancer" refers to a broad category of malignant illnesses that can affect various bodily sections. These disorders are typified by the fast and uncontrollably forming aberrant cells that can aggregate to create a growth or tumor or spread throughout the body to trigger aberrant growth at other locations. If the process is not stopped, it can continue until the organism dies. Surgery, radiation therapy, and pharmaceuticals (cancer chemotherapeutic agents) are the primary treatment modalities for advanced stage cancer in humans. Chemotherapeutic treatments for cancer can sometimes cure the disease as well as prolong its course and temporarily relieve its symptoms. Though they have greater adverse effects, many hundreds of chemical variations of the known class of cancer chemotherapeutic drugs have been synthesized.

1.3. Ayurvedic Concept of Cancer:

The Samhita Charaka and Sushruta called the corresponding conditions to cancer "granthi" and "arbuda. "Granthi" and "Arbuda" may cause inflammation or not depending on the doshas at play. Disease is caused by the body's "Vata, Pitta, and Kapha" doshas; the Ayurvedic concept of health is the harmonious balancing of these doshas in the body, mind, and consciousness. Tridoshicarbudas typically result in a morbid condition because all three major body humors lose mutual coordination, making them cancerous. According to Ayurveda, neoplasms can be categorized based on a range of clinical signs related to tridoshas.

  1. Causes:
  • Tobacco
  • Alcohol
  • Diet
  • Food additives
  • Reproductive and sexual behavior
  • Occupation
  • Pollution
  • Medicines and medical procedures
  • Geophysical factors
  • Infection
  1. Symptoms:
  • Unexplained Weight Loss: Significant weight loss without trying.
  • Fatigue: Persistent tiredness that doesn't improve with rest.
  • Pain: Ongoing pain that may be localized or widespread.
  • Skin Changes: New moles, changes in existing moles, or yellowing of the skin.
  • Changes in Bowel or Bladder Habits: Diarrhea, constipation, or changes in urinary frequency.
  • Unusual Bleeding or Discharge: Blood in stool, urine, or unexpected vaginal bleeding.
  • Lumps or Swellings: New lumps in the breast, testicles, or other parts of the body.
  • Persistent Cough or Hoarseness: A cough that doesn’t go away or voice changes.
  • Difficulty Swallowing: Trouble swallowing or persistent indigestion.
  • Changes in Appetite: Decreased appetite or feelings of fullness.
  • Blood in vomiting.
  • Sore that does not heal.
  • Post menopausal bleeding

3.Types of Cancer: (Bijauliya R.K et al 2017)

1) Cancers of Blood and Lymphatic Systems:

  1. Hodgkin’s disease
  2. Leukemia’s
  3. Lymphomas
  4. Multiple myeloma

2) Skin Cancers:

1. Malignant Melanoma

4.Cancers of Digestive Systems:

    1. Esophageal cancer
    2. Stomach cancer
    3. Cancer of pancreas
    4. Liver cancer
    5. Colon and Rectal cancer
    6. Anal cancer
  1. Cancers of Urinary system:
    1. Kidney cancer
    2. Bladder cancer
    3. Testis cancer
    4. Prostate cancer
  2. Cancers in Women:
    1. Breast cancer
    2. Ovarian cancer
    3. Gynecological cancer
    4. Choriocarcinoma
  3. Miscellaneous Cancers:
    1. Brain cancer
    2. Bone cancer
    3. Characinoid cancer
    4. Nasopharyngeal cancer
    5. Retroperitoneal sarcomas
    6. Soft tissue cancer
    7. Thyroid cancer
  1. Breast cancer:

Breast cancer is the most common cancer and also the primary cause of death due to cancer in female around the World. About 1.38 million new breast cancer cases are diagnosed every year with almost 50% of all breast cancer patients and approximately 60% of deaths occurring in every countries. Developing countries face resource and infrastructure constraints that challenge the objective of improving breast cancer outcomes by timely recognition, diagnosis and management. Different modern medicines are prescribed to treat breast cancer. Medical therapy of breast cancer with antiestrogens such as raloxifene or tamoxifen might avoid breast cancer in individuals who are at increased possibility of developing it. (Muhammad et al 2017)

5.1Types of breast cancer:

      • Non-invasive breast cancer
      • Lobular carcinoma in situ (LCIC)
      • Ductal carcinoma in situ
      • Invasive breast cancer
      • Paget’s disease of the breast
      • Phyllodes tumor
      • Triple-negative breast cancer
      • Pathogenesis of breast cancer
      • Causative factors and associated risks of breast carcinoma
      • A global prospective
      • Infiltrating ductal carcinoma
      • Medullary carcinoma
      • Mucinous carcinoma
      • Tubular carcinoma
      • Inflammatory breast cancer

5.2.Stages of breast cancer: ( Koo MM et al 2017)

Based on the breast cancer report. The size, nature, and extent to which the tumor cells have                                      infiltrated the breast tissues determine the stage of breast cancer. On the other hand, a tumor in stage 0 is non-invasive, whereas one in stage 4 is invasive. The phases of those tumors are:

Stage 0: This is the non-invasive stage of a tumor, meaning that there is no indication of cell invasion in the surrounding tissues and that both cancerous and non-cancerous cells are contained within the confines of the breast region where the tumor starts to form.

Stage 1: This phase is characterized as invasive breast cancer, and microscopic invasion may occur. There are two categories: 1A and 1B stage.

While stage 1B describes a small collection of cancer cells larger than 0.2 mm discovered in lymph nodes, category 1A describes a tumor that is up to 2 cm in size and does not involve any lymph nodes.

Stage 2 : There are two divisions in Stage 2 as well: 2A and 2B. Stage 2A indicates that there is no tumour in the breast but that the tumour is located in the sentinel or axillary lymph nodes. The tumour cannot be greater than 5 cm, however it can be less or larger than 2 cm. Stage 2B, however, indicates that the tumour may be more than 5 cm in size but is unable to reach the lymph nodes in the axilla.

Stage 3 : The third stage is separated into three subcategories, which are 3A, 3B, and 3C. Of these, stage 3A indicates that there is no tumour in the breast but that it may be present in 4–9 axillary lymph nodes or sentinel lymph nodes, whereas stage 3B indicates that the tumour may be any size but that it has resulted in breast skin swelling or ulceration and may have spread to up to 9 axillary lymph nodes or sentinel lymph nodes. Inflammatory breast cancer, or stage 3B, is characterised by red, heated, and swollen breast tissue. But stage 3C indicates that the tumour has progressed to ten or more axillary lymph nodes, and it has also impacted the below and above the collarbone are lymph nodes.

Stage 4: This stage denotes the spread of cancer to other body organs, such as the liver, brain, lungs, and bones. It is the advanced and metastatic stage of the disease.

Symptoms:

      • Breast lamp and nipple abnormalities
      • Breast pain and breast skin abnormalities
      • Axillary lump
      • Breast ulceration
      • Back pain
      • Breast contour abnormalities
      • Breast infection or inflammation
      • Breast swelling
      • Musculoskeletal pain
      • Breathlessness  

5.2Herbs used in breast cancer : ( McGrowder et al 2020)

      • Ginseng
      • Curcuma longa
      • Camellia sinensis
      • Echinacea
      • Arctium lappa
      • Flaxseed
      • Nigella sativa
      • Garlic
  1. Prostate cancer:

One of the most prevalent cancers and the second most common cause of cancer-related deaths in males is prostate cancer. Malignant cells that start in prostate tissues and grow erratically are known as prostate cancer. This type of cancer causes the volume of each of the prostate gland's cellular components to expand. Prostate cancer is more common in older men. many studies have revealed that 40% of men in their 30s-40s have shown histological evidence of prostate adenocarcinoma. Prostate cancer is caused by several factors such as age, race, diet and heredity. Most of the plants used in this have antioxidant activity, which is due to the presence of phenolic compounds. Nettle is known to exhibit positive effect on the treatment of BPH. The main activity of nettle seems to be exerted by disrupting dihydrotestosterone binding to cytosol and nuclear receptors, explaining the role of the plant in preventing prostate cancer. (Basati Gholam et al 2019)

 6.1Symptoms:

 Difficulty in passing urine

        • Loss of appetite
        • Weight loss
        • Bone pain
        • Pain in pelvis, lower back or hips
        • Erectile dysfunction
        • Blood in urine
        • Weak urine flow
        • Difficulty urinating
        • Frequent urge to urinating
        • Painful ejaculation
        • Blood in semen
        • Swellimg in lower extremities
        • Burning urination

6.2Herbs used in prostate cancer:

        • Panax ginseng
        • Arum palaestinum
        • Androsace
        • Artemisia
        • Salvia trilloba
        • Ocimum tenuiflorum
        • Acanthopanax
        • Embelia ribes
        • Coptis chinensis
        • Fraxinus
        • Psidium guajava
        • Ganoderma lucidum
        • Litchi chinensis
        • Pronus africana
        • Saussurea costus

7. Mechanism on Cancer Therapy:

  1. Directly preventing the growth of cancer cells by promoting the phagocytosis of macrophages and increasing the activity of natural killer cells.
  2. Encouraging cancer cells to undergo apoptosis by raising blood serum levels of implement, interleukin 2 interferon and immunoglobin.
  3. By obstructing the tumors’ blood supply, pushing the cancer to necrotize and preventing its translocation.
  4. Stimulating haemopoietic activity to increase leukocyte and platelet counts. Encouraging the conversion of cancer cells back into healthy cells. 5. Increasing metabolism and halting the development of cancer in healthy cells.

7.1. Oncogenes and Tumor Suppressor Genes:

The oncogenes are known as the first class of genes, which are involved in several cellular processes such as cell division. An overexpression of these genes turns a healthy cells into cancerous cell. However, the second gene group, known as tumors suppressor genes, prevents the development of cancer cells through various means. Oncogenes are overexpressed in cancer cells, whereas tumors suppressor genes are under expressed. summarizes the key tumor suppressor genes and oncogenes, as well as how they contribute to the emergence of cancer. Oncogenes and their byproducts make good targets for cancer therapy. An enzymes topoisomerases, which unwind DNA during replication, are among the other targets. The variety of naturally occurring compounds produced from herbal plants can offer medicinal treatments that target various cancer cell targets. (Bijauliya Rk et al 2017).

       
            Illustration of activity of plants against several types of cancer.png
       

 Fig no.1: Illustration of activity of plants against several types of cancer

8.Some Important Medicinal Plants or Phytoconstituents with Anticancer activities:

      • Aeglemarmelos Correaex Roxb
      • Allium cepa Linn.
      • Allium sativum Linn.
      • Aloe vera Tourn. ex Linn/A. barbadensis Mill.
      • Alpiniagalanga Willd.
      • Berberisvulgaris Linn.
      • Glycyrrhizaglabra Linn.
      • Glycyrrhizaglabra Linn.
      • Malus domestica Borkh /M. pumila Mill/M. Communis DC/M. sylvestris Hort., non-Mill/Pyrus malus linn.in

8.1Aeglemarmelos Correaex Roxb. (Bael: Family: Rutaceae)

Lupeol, isolated from pulp and seeds of A. marmelos, possesses strong anticancer activity against breast cancer, malignant lymphoma, malignant melanoma, malignant ascites and leukemia. A. marmelos possesses significant antioxidant activity and reduces side effects of chemotherapy and radiotherapy.

8.1.1. Bael as an Anticancer Agent:

Preclinical studies have shown that Bael leaf extracts were effective in inhibiting the growth of leukemic K562, T-lymphoid Jurkat, B-lymphoid Raji, erythroleukemic HEL, melanoma Colo38, and breast cancer cell lines MCF7 and MDA-MB-231.12,13 The hydroalcoholic extract of the Bael leaves is also shown to possess antineoplastic effects on the Ehrlich ascites carcinoma in Swiss albino mice.14 The ethanolic extract of the fruit is also shown to possess cytotoxic effect on SKBR3 (human breast adenocarcinoma cells) in vitro.15 Studies have also shown that treatment with the Bael extract did not increase ER? mRNA levels in MCF7 cells and MDA-MB.

       
            bael plant.png
       

 8.2. Allium cepa Linn. (Piyaz/Onion;Family:Liliaceae/Alliaceae)

Helicobacter pylori is inhibited by Diallyl disulphide, quercetin flavonoid, allicin, allin and vitamins(C,E), isolated from bulb of A. cepa, detoxify carcinogen and it also arrest cell cycle from S to G2M phase.

       
            Fig no.3 onion.jpg
       

 Fig no.3: onion

8.3. Allium sativum Linn. (Lasun/garlic;Family:Liliaceae/Alliaceae)

Sulphur compounds (diallyl sulphide, diallyl disulphide, allyl propyl disulphide) and allicin have been isolated from A.sativum bulb. Allicin inhibits growth of stomach, liver, colon, breast and endometrium cancers; while Sulphur compounds inhibit the cancer cells.

       
            Garlic.jpg
       

 Fig no.4: Garlic

8.4. Aloe vera tourn ex linn./A.Barbadensis Mill.

Acemannan (a polysaccharide) extracted from the root, pulp, leaves, or aerial parts of A. vera stimulates the immune system and has substantial anticancer action. Emodin and lectins derived from this herb have potent anticancer and immunoenhancing properties. Aloe-emodin prevents the growth and spread of stomach cancer and other sarcomas by inducing apoptosis. Aloe-emodin exhibits specific anticancer action against neuroectodermal tumours. Alexin B isolated from A. vera has potent anticancer action against leukemia. Its polysaccharides have potent immuno-enhancing and anticancer effects. A.vera includes "super carbohydrates" that protect against certain malignancies, including liver cancer. This herb prevents cancer origin, development, and metastasis. A.vera activates macrophages and releases cytokines that stimulate the body's immunological response.(Pandey Govind 2011).

        
            Aloe vera.jpg
       

Fig no.5: Aloe vera

9.Use of herbal supplement as adjuvants in conventional Anticancer therapies:

Herbal medicines in general were used in conjunction with traditional chemotherapy in the aforementioned adjuvant anticancer therapy studies with the hopes of improving therapeutic benefit and quality of life (QoL) while reducing side effects or problems. Herbal medicines are claimed to have been utilized in the treatment of between 28% and 98% of ethnic Chinese cancer patients in Asia [72–74] and between 25% and 47% of those in North America [75, 76]. The majority of clinical trials or research have been reported mostly, if not exclusively, in China or other Asian nations, and they are hardly cited on PubMed, despite the fact that several herbal medications have been proven to be adjunctive in chemotherapy and radiation therapy.(Yin S.Y et al 2013)

10.Induction of Cancer Cell Apoptosis by Herbal Compounds:

Anticancer medications should kill the malignant cell with the least amount of harm to healthy cells, most often by causing apoptosis. Apaf1/caspase-9-caspases-3 and Fas/TNF receptor-1-caspase-8-caspase-3 are two pathways that cause apoptosis. One characteristic of cancer is resistance to apoptosis. Numerous herbal substances cause cancer cells to undergo apoptosis, suggesting effective antitumor substitutes. For this reason, herbal substances such as podophyllotoxin, vinca alkaloids, taxans, and camptothecins have been used in therapeutic settings. Anticancer substances found in human nutrition include phenols, curcumin (by blocking the NFKB pathway up to 8000 mg/day), ginger, resveratrol (by increasing CD95L expression and CD95 signaling), genistein, and ?-lapachone-genistein (by preventing tyrosine kinas, angiogenesis, and cell cycle arrest in the G2/M phase), biocalein (by stimulating quercetin by releasing cytochrome-c into the cytosol and activating caspase-9), alkaloids (7-hydroxystaurosporine by preventing the cell cycle in the G1 phase in ovarian cancer cells), lectines (Viscum album L.), terpenoid (by suppressing and reducing ornithine decarboxylase and cyclooxgenase-2 or cox-2 and matrix metallopeptidase 9 or MMP 9), and taxans (by stopping mitosis in metaphase and anaphase).(Abdulridha MK et al 2020)


Table 1: List Of Anticancer Plant: (Bijauliya Rk et al 2017)

 

Sr No.

Plant Source

Family

Active Constituents

Use

1

Actinidia chinensis

Actinidiaceae

Saponin, alkaloids, coumarin, isoflavonoids, hecogenin, Vitamins A, B, C

Immune-enhancing, anticancer

2

Aegle marmelos

Rutaceae

Alkaloid, coumarin

Breast cancer, lymphoma, malignant melanoma, cytotoxic, antitumor

3

Agave americana

Agavaceae

Agavegenin

Anticancer

4

Allium sativum

Amaryllidaceae

Allicin

Cytotoxic, anticancer

5

Aloe vera

Asphodelaceae

Aloe-emodin

Anticancer

6

Alpinia galangal

Zingiberaceae

Acetoxy-chavicol-acetate (ACA), Pinocembrin, Galangin

Breast, lung, stomach, colon, prostate cancer; antimutagenic

7

Amoora rohituka

Meliaceae

Amooranin (triterpene acid)

Breast and cervical cancers, cytotoxic, immune-stimulating activity

8

Andrographis paniculata

Acanthaceae

Flavonoids, labdane diterpenoids

Breast and cervical cancers, cytotoxic, immune-stimulating activity

9

Annona muricata

Annonaceae

Acetogenins

Anticancer, cytotoxicity in human lymphocytes and HL-60 cells

10

Apis mellifera

Apidae

Protein

Antitumor

11

Ananas comosus

Bromeliaceae

Bromelain

Cytotoxic activity, leukemia

12

Angelica sinensis

Apiaceae

Polysaccharide "AR-4"

Antitumor activity, cervix cancer, leukemia, sarcoma, pancreatic

Sr No.

Plant Source

Family

Active Constituents

Use

13

Annona

Annonaceae

Acetogenin

Breast cancer

14

Arctium lappa

Asteraceae

Arctigenin

Anticancer

 

 

15

Artemisia asiatica

Asteraceae

Flavonoid, terpenes, monoterpenes

Anti-tumor

16

Astragalus membranaceus

Fabaceae

Swainsonine

Liver cancer

17

Autumn Crocus

Liliaceae

Colchicine

Chemotherapeutic, anticancer

18

Azadirachta indica

Meliaceae

Limonoids, Nimbolide

Antimutagenic, anticancer (breast, lung, liver, oral cavity)

19

Bauhinia variegata

Caesalpiniaceae

Cyanidin glucoside, kaempferol galactoside

Anticancer

20

Berberis vulgaris

Berberidaceae

Berberine

Anticancer, immune-enhancing, antioxidant, anti-inflammatory

21

Betula alba

Betulaceae

Betulinic acid

Prostate cancer, diuretic, anti-inflammatory

22

Betula utilis

Betulaceae

Betulin

Liver and lung cancer

23

Bidens pilosa

Asteraceae

Phenyl-1,3,5-heptatriyne

Anticancer

24

Bolbostemma paniculatum

Cucurbitaceae

Tubeimoside-V

Cytotoxic activity

25

Camellia sinensis

Theaceae

(-)-Epigallocatechin gallate

Anti-mutagenic

26

Cannabis sativa

Cannabaceae

Cannabinoids

Anti-tumor (Hodgkin’s disease, breast, lung, bladder, cervix cancer)

27

Catharanthus roseus

Apocynaceae

Vinblastine, vincristine

Anti-tumor activity

28

Chlorella pyrenoidosa

Chlorellaceae

Lysine, albumin

Anticancer

29

Cinnamomum cassia

Lauraceae

Coumarin

Anticancer, antimitotic activity

30

Colchicum luteum

Liliaceae

Colchicine

Anticancer, mitotic inhibition

31

Combretum caffrum

Combretaceae

Combretastatin

Anticancer

32

Coriandrum sativum

Apiaceae

Beta-carotene, quercetin, rutin

Anti-cancer, stomach, colon cancer, antimutagenic

Sr No.

Plant Source

Family

Active Constituents

Use

34

Daphne mezereum

Thymelaeaceae

Mezerein

Antileukemic activity

35

Echinacea angustifolia

Asteraceae

Arabinogalactan

Anticancer

36

Emblica officinalis

Phyllanthaceae

Emblicanin A and B, quercetin

Hepatoprotective, anticancer properties

37

Fagopyrum esculentum

Polygonaceae

Amygdalin

Anticancer

38

Ginkgo biloba

Ginkgoaceae

Ginkgolides (A & B)

Skin, brain tumors, leukemia

39

Glycine max

Fabaceae

Genistein, daidzein

Anticancer

40

Glycyrrhiza glabra

Fabaceae

Licochalcone-A, Glycyrrhizin

Anticancer

41

Gossypium barbadense

Malvaceae

Gossypol

Colon, lung, prostate, breast, brain cancer

42

Gossypium hirustum

Malvaceae

Tannin, phenol

Antitumor

43

Gunnera perpensa

Gunneraceae

Z-venusol

Anticancer

44

Gyrophora esculenta

Umbilicariaceae

Not specified

Carcinogenesis and metastases, antibacterial, antioxidant

45

Indigofera tinctoria

Fabaceae

Flavonoids, saponins, tannins, phenols, anthraquinone

Carcinogenesis and metastases, cytotoxic

46

Justicia procumbens

Acanthaceae

6?-hydroxy justicidin A (JR6)

Anti-cancer effects

47

Lentinus edodes

Polyporaceae

Lentinan, terpenoids, steroids

Antitumor activity, antithrombotic activity

48

Linum usitatissimum

Linaceae

Lignans

Anticarcinogenic

49

Mentha species

Lamiaceae

Monoterpene ketones, phenolic compounds

Anticancer


CONCLUSION:

This article highlights the contributions of herbal formulation to human health, mainly in cancer treatment. These herbal plants have bioactive compounds that demonstrate significant anticancer activity, including immunomodulatory and antioxidant properties. The careful selection and use of these plants can play a crucial role in enhancing cancer management strategies. Furthermore, this review highlights the importance of exploring and harnessing novel anticancer drugs derived from medicinal plants of foreign origin, which are utilized globally. This article also highlights various important plants and its uses in cancer treatment and mechanism of cancer cell aptosis by herbal compounds. In summary, this paper emphasizes how important herbal formulations are to improving cancer treatment. Numerous therapeutic advantages are provided by the bioactive substances present in medicinal plants, especially through their immunomodulatory and antioxidant qualities, which have been demonstrated to greatly increase anticancer efficacy. When carefully chosen and integrated into treatment plans, these plants may be able to supplement traditional medicines and support more individualized and comprehensive approaches to cancer care. Furthermore, there are exciting prospects for innovation in cancer therapy due to the increased interest in finding and using novel anticancer drugs derived from plants, particularly those from uncharted and distant places. These plants may have special ways of working, such as causing cancer cells to undergo apoptosis, preventing tumor growth, and altering cellular signaling.

REFERENCES

  1. Bijauliya R.k, Alok.S, Singh M and Mishra S.b 2017 A Comprehensive Review on Cancer and Anticancer Herbal Drugs IJPSR Vol 8 Issue 2740-2769
  2. Shu-Yi Yin, Wen-Chi Wei, Feng-Yin Jian, and Ning-Sun Yang, 2013, Therapeutic Applications of Herbal Medicines for Cancer Patients, Hindawi Publishing Corporation.
  3. Manal Khalid Abdulridha, Ali H. Al-Marzoqi, Ghaidaa Raheem Lateef Al-awsi, Shaden M. H. Mubarak, Maryam Hederiform, Abdülmecid Ghasemian,2020,
  4. Anticancer Effects of Herbal Medicine Compounds and Novel Formulations: a Literature Review, Journal of Gastrointestinal Cancer
  5. Pandey Govind 2011 some important anticancer a review international research journal of pharmacy volume 2 edition 7 pg. No 45-52
  6. Mohammadi Ali, mansoori behzad and baradaran behzad 2017 Regulation of mirnas by herbal medicine: An emerging field in cancer therapies Biomedicine & Pharmacotherapy 86 (2017) 262-270.
  7. Arnold T Julia 2023, Integrating ayurvedic medicine into cancer research program’s part 2: Ayurvedic herbs and research opportunities Journal of Ayurveda and Integrative Medicine Volume 14, Issue 2
  8. Thomson M and Ali M: Garlic (Allium sativum): a review of its potential use as an anti-cancer agent. Current Cancer Drug Targets 2003
  9. Kharb M, Jat RK and Gupta A: A review on medicinal plants used as a source of anticancer agents, Int. J. Drug Res. Tech. 2012
  10. Sumantran VN, Tillu G. Cancer, inflammation, and insights from ayurveda. Evid Based Complement Alternat Med 2012
  11. Kumar ADSD, Prakash S, Singh P. Principle of Dravyaguna (ayurvedic pharmacology). Biomed Pharmacol J 2011
  12. N. Lynch, D. Berry, Differences in perceived risks and benefits of herbal, over the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products, Complement. Ther. Med. 15 (2007) 84–91
  13. A.K. Mukherjee, et al., Advances in cancer therapy with plant based natural products, Curr. Med. Chem. 8 (2001) 1467–1486
  14. Taraphdar AK, Roy M, Bhattacharya R. Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Curr Sci. 2001
  15. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacology 2005. Sakarkar D, Deshmukh V. Ethnopharmacological review of traditional medicinal plants for anticancer activity. Int J Pharm Tech Res 2011.
  16. Madhuri S, Pandey Govind. Some anticancer medicinal plants of foreign origin. Curr sci 2009
  17. Pandey Govind, Madhuri S. Some anticancer agents from Plant origin Arch 2008
  18. Gupta Vk, Sharma, SK. Plants as natural Antioxidant. Nat Prod Rad 2006; 326- 334
  19. W. Zhang, Y. Li, G. Zhang, J. Lu, and H. Ou, “Experimental¨ study on MCF-7 cell apoptosis induced by ursolic acid,” Zhong Yao Cai, vol. 28, no. 4, pp. 297– 301, 2005.
  20. G. J. Kell off, J. A. Crowell, V. E. Steele et al., “Progress in cancer chemoprevention: development of diet-derived chemo preventive agents,” Journal of Nutrition, vol. 130, no. 2, supplement, pp. 467S–471S.
  21. Muhammad Akram, Mehwish Iqbal, Muhammad Daniyal and khan UK 2017 Awareness and current knowledge of breast cancer Biol Res (2017) 50:33
  22. Koo MM, Wagner CV and Abel GA etal 2017 Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis Journal of Cancer Epidemiology (48) page no :140-146
  23. Mcgrowder DA, Miller FG and Anderson MS etal 2020 Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action www.mdpi.com/journal / medicines (7) 47.
  24. Coleman M, Quaresma M, Berrino F, Lutz JM, Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008.
  25. Anderson B, Yip C, Smith R, Shyann R, Sener S, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007.
  26. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013.
  27. Lundqvist A; Andersson E; Ahlberg, I; Nilbert M; Gerdtham, U. Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis. Eur. J. Public Health 2016,804-813
  28. Azamjah N; Soltan-Zadeh Y; Zayeri, F. Global trend of breast cancer mortality rate: A 25-year study. Asian Pac. J. Cancer Prev. 2019, 2015–2020
  29. Hashmi, A.A; Hashmi, K.A; Irfan M; Khan, S.M; Edhi, M.M; Ali, J.P; Hashmi, S.K; Asif, H; Faridi, N; Khan, A. Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters. BMC Res. Notes 2019, 1–5
  30. Gholam Basati, Pardis Ghanadi, Saber Abbaszadeh A review of the most important natural antioxidants and effective medicinal plants in traditional medicine on prostate cancer and its disorders Biol res 2017
  31. Coleman M, Quaresma M, Berrino F, Lutz JM, Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008
  32. Anderson B, Yip C, Smith R, Shyyan R, Sener S, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007. Cancer 2008
  33. Dreosti I E 1996: Bioactive ingredients: antioxidants and polyphenols in tea. Nutr Rev, 54(11); S51-8.
  34. Kim M, Hagiwara N, Smith SJ, Yamamoto T, Yamane T and Takahashi T: Preventive effect of green tea polyphenols on colon carcinogenesis. In: Huang MT, Osawa T, Ho CT, Rosen RT, eds. Food phytochemicals for cancer prevention II. Teas, spices and herbs. Washington, DC: American Chemical Society 1994, 51–5.
  35. Lea MA, Xiao Q, Sadhukhan AK, Cottle S, Wang, ZY and Yang CS: Inhibitory effects of tea extracts and (-) epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett; 1993; 68: 231-6. 
  36. Hamzaoglu I, Saribeyoglu K, Durak H, Karahasanoglu T, Bayrak I and Altug T: Protective covering of surgical wounds with honey impedes tumor implantation, Archives of Surgery 2002; 135: 1414.
  37. Gerber B., Scholz C., Reimer T., Briese V., and Janni W., Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review, Breast Cancer Research and Treatment. (2006) 95, no. 3, 199–209, 2-s2.
  38. Lesperance M. L., Olivotto I. A., Forde N., Zhao Y., Speers C., Foster H., Tsao M., macpherson N., and Hoffer A., Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study, Breast Cancer Research and Treatment. (2002) 76, no. 2, 137–143, 2s2.
  39. Willett W. C. And Stampfer M. J., What vitamins should I be taking, doctor, The New England Journal of Medicine. (2001) 345, no. 25, 1819– 1824.
  40. Ingram D., Sanders K., Kolybaba M., and Lopez D., Case-control study of phyto-oestrogens and breast cancer, The Lancet. (1997) 350, no. 9083, 990– 994. Gupta VK, Sharma, SK.  Plants as natural antioxidants.  Nat Prod Rad 2006; 5(4):326-334. 
  41. Olidori MC.  Antioxidant micronutrients in the prevention of age-related diseases. J Postgrad Med 2003; 49:229-235. 
  42. Pandey Govind.  Active principles and median lethal dose Curcuma longa Linn. Int Res J Pharm 2011; 2(5):239-241. 
  43. Pandey Govind, Pandey SP.  Phytochemical and toxicity study of Emblica officinalis (Amla).  Int Res J Pharm 2011; 2(3):270-272. 
  44. Hirazumi A, Furusawa E.  An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) with antitumour activity.  Phytother Res 1999; 13:380-387.  
  45. Pandey Govind, Madhuri S. Pharmacological activities of Ocimum sanctum (Tulsi):  A review. Int J Pharmaceu Sci Rev Res 2010; 5(1):61-66. 
  46. Madhuri S, Pandey Govind.  Anticancer activity of Withania somnifera  Dunal  (Ashwagandha).  Indian Drugs, 2009; 46(8):603-609
  47. Madhuri S., Govind Pandey and V. B. Gupta. Common agriculture plants as anticancer (Abs.). Abstracts (I): 314-315 (2007) (Paper presented in the International Conference on Sustainable Agriculture for Food, Bio-energy and Livelihood Security at Jabalpur, M.P. in February, 2007). 
  48. Madhuri, S., Govind Pandey and Asha Khanna. Antioxidant vegetables useful in cancers and other diseases (Abs.). Abstract, 341 342 (2007) (Paper presented in the Bhartiya Vigyan Sammelan of Vijnana Bharati, M.P. Council of Science & Technology and Rajiv Gandhi Technological University, Bhopal, M.P., 23-25 November, 2007). 
  49. Bandaranayake WM. Bioactivities: Bioactive compound and chemical constituents of mangrove plants. Wetl. Ecol. Manage. 10: 421-452 (2002). 
  50. Iinuma M, Tosa H et.al., Two new xanthones in the underground part of Calophyllum inophyllum. Hetrocycles. 37: 833 838 (1994). 
  51. Bose CK. Possible role of Moringa oleifera Lam. Root in epithelial ovarian cancer. Med. Gen. Med. 9(1): 26 (2007).
  52. Zheng GQ, Kenney PM Pand L.K.T. Lam. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J. Nat. Prod. 55: 999-1003 (1992)

Reference

  1. Bijauliya R.k, Alok.S, Singh M and Mishra S.b 2017 A Comprehensive Review on Cancer and Anticancer Herbal Drugs IJPSR Vol 8 Issue 2740-2769
  2. Shu-Yi Yin, Wen-Chi Wei, Feng-Yin Jian, and Ning-Sun Yang, 2013, Therapeutic Applications of Herbal Medicines for Cancer Patients, Hindawi Publishing Corporation.
  3. Manal Khalid Abdulridha, Ali H. Al-Marzoqi, Ghaidaa Raheem Lateef Al-awsi, Shaden M. H. Mubarak, Maryam Hederiform, Abdülmecid Ghasemian,2020,
  4. Anticancer Effects of Herbal Medicine Compounds and Novel Formulations: a Literature Review, Journal of Gastrointestinal Cancer
  5. Pandey Govind 2011 some important anticancer a review international research journal of pharmacy volume 2 edition 7 pg. No 45-52
  6. Mohammadi Ali, mansoori behzad and baradaran behzad 2017 Regulation of mirnas by herbal medicine: An emerging field in cancer therapies Biomedicine & Pharmacotherapy 86 (2017) 262-270.
  7. Arnold T Julia 2023, Integrating ayurvedic medicine into cancer research program’s part 2: Ayurvedic herbs and research opportunities Journal of Ayurveda and Integrative Medicine Volume 14, Issue 2
  8. Thomson M and Ali M: Garlic (Allium sativum): a review of its potential use as an anti-cancer agent. Current Cancer Drug Targets 2003
  9. Kharb M, Jat RK and Gupta A: A review on medicinal plants used as a source of anticancer agents, Int. J. Drug Res. Tech. 2012
  10. Sumantran VN, Tillu G. Cancer, inflammation, and insights from ayurveda. Evid Based Complement Alternat Med 2012
  11. Kumar ADSD, Prakash S, Singh P. Principle of Dravyaguna (ayurvedic pharmacology). Biomed Pharmacol J 2011
  12. N. Lynch, D. Berry, Differences in perceived risks and benefits of herbal, over the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products, Complement. Ther. Med. 15 (2007) 84–91
  13. A.K. Mukherjee, et al., Advances in cancer therapy with plant based natural products, Curr. Med. Chem. 8 (2001) 1467–1486
  14. Taraphdar AK, Roy M, Bhattacharya R. Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Curr Sci. 2001
  15. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacology 2005. Sakarkar D, Deshmukh V. Ethnopharmacological review of traditional medicinal plants for anticancer activity. Int J Pharm Tech Res 2011.
  16. Madhuri S, Pandey Govind. Some anticancer medicinal plants of foreign origin. Curr sci 2009
  17. Pandey Govind, Madhuri S. Some anticancer agents from Plant origin Arch 2008
  18. Gupta Vk, Sharma, SK. Plants as natural Antioxidant. Nat Prod Rad 2006; 326- 334
  19. W. Zhang, Y. Li, G. Zhang, J. Lu, and H. Ou, “Experimental¨ study on MCF-7 cell apoptosis induced by ursolic acid,” Zhong Yao Cai, vol. 28, no. 4, pp. 297– 301, 2005.
  20. G. J. Kell off, J. A. Crowell, V. E. Steele et al., “Progress in cancer chemoprevention: development of diet-derived chemo preventive agents,” Journal of Nutrition, vol. 130, no. 2, supplement, pp. 467S–471S.
  21. Muhammad Akram, Mehwish Iqbal, Muhammad Daniyal and khan UK 2017 Awareness and current knowledge of breast cancer Biol Res (2017) 50:33
  22. Koo MM, Wagner CV and Abel GA etal 2017 Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis Journal of Cancer Epidemiology (48) page no :140-146
  23. Mcgrowder DA, Miller FG and Anderson MS etal 2020 Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action www.mdpi.com/journal / medicines (7) 47.
  24. Coleman M, Quaresma M, Berrino F, Lutz JM, Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008.
  25. Anderson B, Yip C, Smith R, Shyann R, Sener S, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007.
  26. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013.
  27. Lundqvist A; Andersson E; Ahlberg, I; Nilbert M; Gerdtham, U. Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis. Eur. J. Public Health 2016,804-813
  28. Azamjah N; Soltan-Zadeh Y; Zayeri, F. Global trend of breast cancer mortality rate: A 25-year study. Asian Pac. J. Cancer Prev. 2019, 2015–2020
  29. Hashmi, A.A; Hashmi, K.A; Irfan M; Khan, S.M; Edhi, M.M; Ali, J.P; Hashmi, S.K; Asif, H; Faridi, N; Khan, A. Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters. BMC Res. Notes 2019, 1–5
  30. Gholam Basati, Pardis Ghanadi, Saber Abbaszadeh A review of the most important natural antioxidants and effective medicinal plants in traditional medicine on prostate cancer and its disorders Biol res 2017
  31. Coleman M, Quaresma M, Berrino F, Lutz JM, Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008
  32. Anderson B, Yip C, Smith R, Shyyan R, Sener S, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007. Cancer 2008
  33. Dreosti I E 1996: Bioactive ingredients: antioxidants and polyphenols in tea. Nutr Rev, 54(11); S51-8.
  34. Kim M, Hagiwara N, Smith SJ, Yamamoto T, Yamane T and Takahashi T: Preventive effect of green tea polyphenols on colon carcinogenesis. In: Huang MT, Osawa T, Ho CT, Rosen RT, eds. Food phytochemicals for cancer prevention II. Teas, spices and herbs. Washington, DC: American Chemical Society 1994, 51–5.
  35. Lea MA, Xiao Q, Sadhukhan AK, Cottle S, Wang, ZY and Yang CS: Inhibitory effects of tea extracts and (-) epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett; 1993; 68: 231-6. 
  36. Hamzaoglu I, Saribeyoglu K, Durak H, Karahasanoglu T, Bayrak I and Altug T: Protective covering of surgical wounds with honey impedes tumor implantation, Archives of Surgery 2002; 135: 1414.
  37. Gerber B., Scholz C., Reimer T., Briese V., and Janni W., Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review, Breast Cancer Research and Treatment. (2006) 95, no. 3, 199–209, 2-s2.
  38. Lesperance M. L., Olivotto I. A., Forde N., Zhao Y., Speers C., Foster H., Tsao M., macpherson N., and Hoffer A., Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study, Breast Cancer Research and Treatment. (2002) 76, no. 2, 137–143, 2s2.
  39. Willett W. C. And Stampfer M. J., What vitamins should I be taking, doctor, The New England Journal of Medicine. (2001) 345, no. 25, 1819– 1824.
  40. Ingram D., Sanders K., Kolybaba M., and Lopez D., Case-control study of phyto-oestrogens and breast cancer, The Lancet. (1997) 350, no. 9083, 990– 994. Gupta VK, Sharma, SK.  Plants as natural antioxidants.  Nat Prod Rad 2006; 5(4):326-334. 
  41. Olidori MC.  Antioxidant micronutrients in the prevention of age-related diseases. J Postgrad Med 2003; 49:229-235. 
  42. Pandey Govind.  Active principles and median lethal dose Curcuma longa Linn. Int Res J Pharm 2011; 2(5):239-241. 
  43. Pandey Govind, Pandey SP.  Phytochemical and toxicity study of Emblica officinalis (Amla).  Int Res J Pharm 2011; 2(3):270-272. 
  44. Hirazumi A, Furusawa E.  An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) with antitumour activity.  Phytother Res 1999; 13:380-387.  
  45. Pandey Govind, Madhuri S. Pharmacological activities of Ocimum sanctum (Tulsi):  A review. Int J Pharmaceu Sci Rev Res 2010; 5(1):61-66. 
  46. Madhuri S, Pandey Govind.  Anticancer activity of Withania somnifera  Dunal  (Ashwagandha).  Indian Drugs, 2009; 46(8):603-609
  47. Madhuri S., Govind Pandey and V. B. Gupta. Common agriculture plants as anticancer (Abs.). Abstracts (I): 314-315 (2007) (Paper presented in the International Conference on Sustainable Agriculture for Food, Bio-energy and Livelihood Security at Jabalpur, M.P. in February, 2007). 
  48. Madhuri, S., Govind Pandey and Asha Khanna. Antioxidant vegetables useful in cancers and other diseases (Abs.). Abstract, 341 342 (2007) (Paper presented in the Bhartiya Vigyan Sammelan of Vijnana Bharati, M.P. Council of Science & Technology and Rajiv Gandhi Technological University, Bhopal, M.P., 23-25 November, 2007). 
  49. Bandaranayake WM. Bioactivities: Bioactive compound and chemical constituents of mangrove plants. Wetl. Ecol. Manage. 10: 421-452 (2002). 
  50. Iinuma M, Tosa H et.al., Two new xanthones in the underground part of Calophyllum inophyllum. Hetrocycles. 37: 833 838 (1994). 
  51. Bose CK. Possible role of Moringa oleifera Lam. Root in epithelial ovarian cancer. Med. Gen. Med. 9(1): 26 (2007).
  52. Zheng GQ, Kenney PM Pand L.K.T. Lam. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J. Nat. Prod. 55: 999-1003 (1992)

Photo
Aarti Harjan
Corresponding author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute Of Pharmacy, Maregaon

Photo
Atharva Pusalwar
Co-author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute Of Pharmacy, Maregaon

Photo
Dr. Ashish Kandalkar
Co-author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute Of Pharmacy, Maregaon

Photo
Supriya Bhagat
Co-author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute Of Pharmacy, Maregaon

Photo
Dr. Nilesh Chachda
Co-author

Shri Chhatrapati Shahu Maharaj Shikshan Sanstha Institute Of Pharmacy, Maregaon

Aarti Harjan*, Atharva Pusalwar, Dr. Ashish Kandalkar, Supriya Bhagat, Dr. Nilesh Chachda, Herbal Drugs Used as Anticancer Agent, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 12, 2280-2292. https://doi.org/10.5281/zenodo.14500615

More related articles
Drug Utilization Evaluation Among Hypertensive Pat...
Attahir Sa’ad Ayuba, Dr. Ado Shehu, Nikhil Nama, Dr. Monica Lal...
Epigenetic Modification in Alzheimer Disease...
Salunke Chaitali B., Deokar Shivprasad , Dr. Kawade Rajendra , Pa...
Advancements And Challenges In The Integration Of ...
Patil Jayesh Hilal, Patil Harish , Chordiya Harshita , Panpatil A...
Formulation And Evaluation Of Gastroretentive Floating Tablet Of Atorvastatin Ca...
Toushiba Javed Khan , Sheikh Samir Md. Mustafa , Asra S. Shaikh, Zoya F. Shaikh, Mohammad Jawwad, Am...
A Review On Liposomes As Drug Delivery System...
Ayush S. Jaiswal, Rekha Gaukande, Gajanan Sanap, ...
Related Articles
Formulation And Evaluation Of Fast Dissolving Sodium Diclofenac Sodium Tablet...
Sujit S. Shinde , Sachitanand B. biradar , Avinash A Bhagat , Madan K. Shinde , ...
A Narrative Review on Association of Anaemia with Tuberculosis...
Kavitha Sekar , Glory Ann Varghese, Dr. Divyashree N., Sadiya Samreen, Aarabhi I. U., Madeeha Abrar,...
Review Of Tuberculosis Caused By Bacteria...
Tekchand Manohar Pawar, Akash Vitthal Kaulange, Vikram Jaysingh Pansare, Yogesh Ankush Narute , ...
Drug Utilization Evaluation Among Hypertensive Patients in a Tertiary Care Setti...
Attahir Sa’ad Ayuba, Dr. Ado Shehu, Nikhil Nama, Dr. Monica Lal, Dr. Amit Bhargav, Dr. Ritika Bans...
More related articles
Drug Utilization Evaluation Among Hypertensive Patients in a Tertiary Care Setti...
Attahir Sa’ad Ayuba, Dr. Ado Shehu, Nikhil Nama, Dr. Monica Lal, Dr. Amit Bhargav, Dr. Ritika Bans...
Epigenetic Modification in Alzheimer Disease...
Salunke Chaitali B., Deokar Shivprasad , Dr. Kawade Rajendra , Pathade Pratiksha , ...
Advancements And Challenges In The Integration Of Artificial Intelligence With H...
Patil Jayesh Hilal, Patil Harish , Chordiya Harshita , Panpatil Ashishkumar, Deore Rashmi , Sarode S...
Drug Utilization Evaluation Among Hypertensive Patients in a Tertiary Care Setti...
Attahir Sa’ad Ayuba, Dr. Ado Shehu, Nikhil Nama, Dr. Monica Lal, Dr. Amit Bhargav, Dr. Ritika Bans...
Epigenetic Modification in Alzheimer Disease...
Salunke Chaitali B., Deokar Shivprasad , Dr. Kawade Rajendra , Pathade Pratiksha , ...
Advancements And Challenges In The Integration Of Artificial Intelligence With H...
Patil Jayesh Hilal, Patil Harish , Chordiya Harshita , Panpatil Ashishkumar, Deore Rashmi , Sarode S...